# V1 Empirics Check — google/gemini-3-flash-preview (Variant C)

**Model:** google/gemini-3-flash-preview
**Variant:** C
**Date:** 2026-03-25T13:02:23.790631

---

This review evaluates the paper "The Exit Option That Wasn't: Medical Aid in Dying Laws and End-of-Life Medicare Spending" from the perspective of a seasoned econometrician.

### 1. Idea Fidelity
The paper adheres closely to the original idea manifest. It correctly identifies the 2016–2021 wave of MAiD legalization as the primary source of variation, utilizes the specified CMS Geographic Variation PUF data, and implements the suggested Callaway–Sant’Anna (2021) estimator. The research question—testing the "cultural spillover" or "exit option" hypothesis—matches the manifest’s objective. The paper adds a methodological layer regarding TWFE bias that was not explicitly in the manifest but is a logical extension of using modern staggered DiD tools.

### 2. Summary
The paper evaluates whether the legalization of Medical Aid in Dying (MAiD) in seven U.S. jurisdictions (2016–2021) shifted Medicare spending from acute inpatient care toward hospice services. Using a staggered difference-in-differences design on administrative county-year data, the author finds no statistically or economically significant impact on spending composition, suggesting that MAiD laws do not generate the broad "cultural spillovers" hypothesized by some advocates and health economists.

### 3. Essential Points

*   **Cluster-Robust Inference and the Number of Treated Units:** With only 7 treated state clusters, the asymptotic assumptions underlying the cluster-robust standard error (CRSE) are extremely fragile. While the author correctly identifies this and provides Wild Cluster Bootstrap (WCB) $p$-values in Table 2, the WCB $p$-values for the Callaway–Sant'Anna (CS) estimates (the paper's preferred specification) are missing. Given the sign-flip between TWFE and CS, the paper’s contribution hinges on the robustness of the CS null. The author must provide bootstrap-based inference for the CS ATT to ensure the null isn't simply a result of inflated standard errors in the CS framework.
*   **The Problem of "Medicare Fee-for-Service" Composition:** The Geographic Variation PUF only covers Medicare FFS. If MAiD laws primarily influence the behavior of relatively younger, wealthier, or more "system-aware" beneficiaries who are disproportionately enrolled in Medicare Advantage (MA), the administrative data in this paper would miss the effect entirely. Given that MA penetration is high in several treated states (CA, CO), the author must address whether FFS beneficiaries are a representative sample for testing "cultural spillovers" in end-of-life care.
*   **Intensity of Treatment vs. Binary Indicator:** MAiD utilization is notoriously slow to ramp up. In California, utilization doubled between 2017 and 2021 but remained at <0.5% of deaths. By treating "legalization year" as a binary switch, the DiD may be averaging out a tiny, growing effect over a short post-period. The author should test for a "dosage" effect or a trend-break specification to ensure that a gradual shift in norms isn't being masked by a static ATT estimate.

### 4. Suggestions

**Econometric Specifics:**
*   **Event Study Visualization:** For an empirical paper of this nature, the absence of an event-study plot (Coefficient Plot) is a significant omission. Relying on the Appendix's textual description of Sun-Abraham results is insufficient for an AER: Insights format. A single figure showing the dynamic ATT for hospice and inpatient spending would immediately establish the validity of the parallel trends assumption and the lack of a post-treatment "ramp-up."
*   **Always-Treated Units:** The author excludes OR, WA, MT, and VT. While correct for the CS estimator's baseline, these states could be used in a "long-run" descriptive analysis. If a "cultural spillover" takes 20 years to manifest (as the Discussion suggests), the author should show a simple comparison of spending residuals between these early-adopters and the rest of the country.
*   **Weighting:** Are the regressions weighted by the number of beneficiaries? Medicare spending per capita is much more volatile in small rural counties. If unweighted, the "precisely estimated null" might be driven by noise in low-population counties.

**Institutional Context & Data:**
*   **The "Six-Month" Prognosis Link:** Both Hospice eligibility and MAiD eligibility require a <6-month prognosis. This is the "mechanical" link the paper should exploit. Is there data in the PUF for the *length of stay* in hospice? A "cultural spillover" might not change *whether* someone enters hospice, but *how early* they enter (thereby increasing spending).
*   **Standardized vs. Actual Payments:** The use of standardized payments is excellent practice to remove geographic price variation. However, it would be useful to note if any of the MAiD-adopting states underwent concurrent palliative care payment reforms (e.g., state-level Medicaid waivers) that could confound the Medicare-only results.
*   **External Validity of DC/NJ/ME:** These are small jurisdictions compared to CA/CO. The author should consider a "leave-one-out" sensitivity check for the CS estimator to ensure the results aren't dominated by California’s specific healthcare market.

**Writing and Presentation:**
*   **Magnitude Benchmarking:** The author notes a \$40 per-capita increase in hospice spending would be a 15% shift. To make this "economically meaningful," convert this to aggregate dollars. What would a 5% shift in hospice utilization represent in terms of total Medicare savings? This helps the reader understand the "fiscal neutrality" argument more clearly.
*   **Table 4 (Standardized Effect Sizes):** This table is currently full of "NA" values in the draft. Completing this is essential for the AER: Insights "At-a-Glance" style.
*   **Mechanism Discussion:** The paper mentions "physician training" and "advance directives." If possible, the author should look at a proxy for these mechanisms (e.g., billing codes for "Advance Care Planning" – CPT 99497) which are also available in some CMS public files. This would bridge the gap between the "policy" and the "spending" result.

**Verdict:** The paper is well-structured and uses the correct modern toolkit. The shift from a significant TWFE result to a robust CS null is a strong hook. Addressing the MA participation and the visual evidence of trends would bring this to a submittable standard.
